Reading the tape
NASDAQ: OABI
OmniAb, Inc.
Healthcare · Biotechnology
Market Cap
$160.48M
52w High
$2.30
52w Low
$1.22
P/E
-2.78
Volume
290.66K
Outstanding Shares
113.82M
Price vs Fundamentals
Why The Stock Is Moving
Likely fundamental deteriorationModerate confidence
Note: The most recent financial data is over 3 months old. Metrics shown may not reflect the latest reporting period.
1Y Price: -16.07%Revenue (TTM): -29.27%FCF (TTM): 10.88%P/S: 39th pct
What changed
The stock fell 16.07% over the last year. Revenue declined 29.27% over the trailing twelve months. Operating margin moved from -282.3% to -383.15%. Free cash flow grew 10.88% over the trailing twelve months.
What the market seems to be pricing
The market is reacting to weaker business momentum more than just compressing the valuation multiple. Even if the shares already screen cheap on P/S, investors are still discounting lower future earnings power.
What would invalidate this read
Operating margin stands at -383.15%. Revenue declined 29.27% — this read reverses if that trend stabilizes. If margins and cash flow stabilize while the stock stays depressed, the gap shifts from fundamental damage toward pure multiple compression.
Company profile
OmniAb, Inc., a biotechnology company, provides therapeutic antibody discovery technologies in the United States.
CEOMatthew W. Foehr
SectorHealthcare
IndustryBiotechnology
Employees114
IPO dateSep 30, 2021
Valuation
Forward P/E—
EV/EBITDA-4.12
Enterprise value$205.03M
Stock splits
No stock splits recorded for this ticker.
Profitability & growth
Revenue growth-22.47%
Gross margin73.45%▼118.17%vs FY2024
Operating margin-383.15%▼35.72%vs FY2024
ROE-24.26%▼12.48%vs FY2024
Analyst consensus
RatingBuy
Target price$4.00▲183.69%
9
Buy
0
Hold
0
Sell
Analyst ratings tend to be lagging indicators. Use as one signal among many.
Earnings
Full quarter-by-quarter history of actuals vs estimates. Switch into compare mode to inspect one metric year-over-year.
Next report
May 7, 2026
Q2 FY26 · EPS est -$0.10 · Revenue est $5.6M
View